Acquisitions and Divestitures (Tables)

3 Months Ended

Mar. 31, 2012

Acquisitions and Divestitures

Schedule of fair value of consideration transferred

	Fair Value at the Acquisition Date
Cash	$	363,405
Contingent consideration	179,135
Total fair value of consideration transferred	$	542,540

Schedule of purchase price allocated to assets acquired and liabilities assumed at acquisition date

	March 7, 2012
Working capital (1)	$	11,876
Property, plant and equipment	2,559
Platform technology intangible asset (2)	356,800
In-process research and development product rights	201,900
Net deferred tax liability (3)	(175,673)
Total identifiable net assets	397,462
Goodwill	145,078
Net assets acquired	$	542,540

(1)Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.

(2)Platform technology related to the Avilomics™ discovery platform which is being amortized over a useful life of seven years based on the estimated useful life of the underlying process.

(3)Includes current deferred income tax asset of $14.7 million and non-current deferred tax liability of $190.4 million.